Clinical Trial Update: Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation. [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating pegylated interferon in combination with ribavirin for hepatitis C after liver transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED